MarketCap
Facebook
X
Telegram
Mersana Therapeutics ROCE | MRSN
ROCE Jährlich Mersana Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | -36.18 | -723.31 | -40.08 | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -36.18 | -723.31 | -266.53 |
ROCE anderer Aktien in der Pharmaeinzelhändler
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Tarsus Pharmaceuticals
TARS
|
-16.64 | $ 73.9 | 4.32 % | $ 3.09 B |  USA |
 |
Bio-Techne Corporation
TECH
|
11.95 | $ 72.83 | -0.01 % | $ 11.4 B | USA |
 |
Sage Therapeutics
SAGE
|
-92.97 | - | - | $ 527 M | USA |
 |
Taro Pharmaceutical Industries Ltd.
TARO
|
1.01 | - | - | $ 1.62 B |  Israel |
 |
Cabaletta Bio
CABA
|
-149.87 | $ 1.43 | -5.0 % | $ 144 M | USA |
 |
Forma Therapeutics Holdings
FMTX
|
-34.91 | - | - | $ 958 M | USA |
 |
Blueprint Medicines Corporation
BPMC
|
-60.1 | - | - | $ 8.14 B | USA |
 |
Horizon Therapeutics Public Limited Company
HZNP
|
7.56 | - | - | $ 26.6 B |  Irlanda |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
-51.03 | $ 4.12 | -8.35 % | $ 35.1 M | USA |
 |
Paratek Pharmaceuticals
PRTK
|
27.02 | - | - | $ 121 M | USA |
 |
DBV Technologies S.A.
DBVT
|
-83.7 | $ 11.55 | 4.52 % | $ 1.61 B |  France |
 |
Gilead Sciences
GILD
|
44.14 | $ 170.68 | 0.8 % | $ 212 B | USA |
 |
Taysha Gene Therapies
TSHA
|
-44.75 | $ 4.28 | -2.06 % | $ 1.37 B | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
-379.93 | - | -14.27 % | $ 1.7 M |  Singapore |
 |
Adverum Biotechnologies
ADVM
|
-196.79 | - | - | $ 86.2 M | USA |
 |
Unity Biotechnology
UBX
|
-480.0 | - | -33.41 % | $ 3.37 M | USA |
 |
iTeos Therapeutics
ITOS
|
-27.03 | - | - | $ 411 M | USA |
 |
Gossamer Bio
GOSS
|
-156.9 | $ 11.2 | 5.21 % | $ 2.56 B | USA |
 |
GeoVax Labs
GOVX
|
-565.71 | $ 0.11 | -22.17 % | $ 105 K | USA |
 |
United Therapeutics Corporation
UTHR
|
20.39 | $ 588.33 | 1.01 % | $ 26.1 B | USA |
 |
Seelos Therapeutics
SEEL
|
120.86 | - | -47.76 % | $ 6.27 M | USA |
 |
Vericel Corporation
VCEL
|
2.52 | $ 59.02 | 1.08 % | $ 2.97 B | USA |
 |
Veracyte
VCYT
|
4.29 | $ 24.05 | -7.21 % | $ 1.89 B | USA |
 |
Advaxis
ADXS
|
429.74 | - | -9.65 % | $ 45.9 M | USA |
 |
GlaxoSmithKline plc
GSK
|
19.97 | $ 51.25 | -0.56 % | $ 208 B |  Britain |
 |
Vir Biotechnology
VIR
|
-52.67 | $ 13.17 | -3.48 % | $ 1.82 B | USA |
 |
Viking Therapeutics
VKTX
|
-61.55 | $ 28.67 | -1.1 % | $ 3.23 B | USA |
 |
Vanda Pharmaceuticals
VNDA
|
-43.97 | $ 4.07 | -0.49 % | $ 240 M | USA |
 |
Verrica Pharmaceuticals
VRCA
|
-49.25 | $ 3.55 | -1.11 % | $ 37.8 M | USA |
 |
Vertex Pharmaceuticals Incorporated
VRTX
|
19.16 | $ 547.74 | -0.57 % | $ 140 B | USA |
 |
Kiromic BioPharma
KRBP
|
188.88 | - | 6.61 % | $ 3.08 M | USA |
 |
vTv Therapeutics
VTVT
|
-39.41 | $ 20.88 | -1.42 % | $ 83.8 M | USA |
 |
CNS Pharmaceuticals
CNSP
|
-353.49 | $ 3.81 | -3.3 % | $ 1.69 M | USA |
 |
Voyager Therapeutics
VYGR
|
-58.41 | $ 1.82 | -8.54 % | $ 107 M | USA |
 |
Calithera Biosciences
CALA
|
-206.33 | - | -10.95 % | $ 876 K | USA |
 |
Applied Molecular Transport
AMTI
|
-209.11 | - | - | $ 10.1 M | USA |
 |
Wave Life Sciences Ltd.
WVE
|
-40.22 | $ 3.41 | -2.01 % | $ 575 M | Singapore |
 |
Molecular Templates
MTEM
|
-248.48 | - | -23.43 % | $ 495 K | USA |
 |
Exicure
XCUR
|
-107.82 | $ 1.08 | 21.31 % | $ 6.8 M | USA |
 |
Immunome
IMNM
|
-35.12 | $ 18.65 | -3.67 % | $ 1.63 B | USA |
 |
Xeris Pharmaceuticals
XERS
|
9.09 | $ 15.81 | -0.35 % | $ 2.54 B | USA |
 |
X4 Pharmaceuticals
XFOR
|
-32.82 | $ 3.24 | -2.7 % | $ 137 M | USA |
 |
Xencor
XNCR
|
-22.77 | $ 39.42 | 2.16 % | $ 2.93 B | USA |
 |
INmune Bio
INMB
|
-197.97 | $ 1.09 | -3.54 % | $ 27 M | USA |
 |
Insmed Incorporated
INSM
|
-69.43 | $ 119.55 | 2.97 % | $ 23.8 B | USA |
 |
Ionis Pharmaceuticals
IONS
|
-7.82 | $ 28.02 | -9.63 % | $ 4.48 B | USA |
 |
BioXcel Therapeutics
BTAI
|
52.86 | $ 0.07 | 9.81 % | $ 855 K | USA |
 |
InflaRx N.V.
IFRX
|
-43.45 | $ 1.21 | -7.63 % | $ 81.4 M |  Germany |
 |
XTL Biopharmaceuticals Ltd.
XTLB
|
-34.24 | $ 1.78 | 16.33 % | $ 1.2 B | Israel |
 |
22nd Century Group
XXII
|
-67.97 | $ 1.46 | -10.43 % | $ 269 K | USA |